Suchergebnisse - "Pytel, Dariusz"

PubPharm (8)

1

Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal Cancer

enthalten in: Current cancer drug targets | 2020

von Rozpędek, W. | Pytel, D. | Wawrzynkiewicz, A. | +5

2

Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment

enthalten in: Current medicinal chemistry | 2019

von Rozpędek, W. | Pytel, D. | Nowak-Zduńczyk, A. | +4

3

Inhibition of PERK-dependent pro-adaptive signaling pathway as a promising approach for cancer treatment

enthalten in: Polski przeglad chirurgiczny | 2017

von Rozpędek, W. | Pytel, D. | Dziki, �. | +4

4

DNA damage and repair of head and neck cancer cells after radio- and chemotherapy

enthalten in: Zeitschrift fur Naturforschung. C, Journal of biosciences | 2009

von Rusin, P. | Walczak, A. | Zwierzchlejska, A. | +8

5

Tyrosine kinase blockers : new hope for successful cancer therapy

enthalten in: Anti-cancer agents in medicinal chemistry | 2009

von Pytel, D. | Sliwinski, T. | Poplawski, T. | +2

6

The role of oncogenic tyrosine kinases in the cellular response to anticancer therapy

enthalten in: Postepy higieny i medycyny doswiadczalnej (Online) | 2007

von Słupianek, A. | Pytel, D. | Majsterek, I.

7

Imatinib (STI571) inhibits DNA repair in human leukemia oncogenic tyrosine kinase-expressing cells

enthalten in: Zeitschrift fur Naturforschung. C, Journal of biosciences | 2006

von Majsterek, I. | Arabski, M. | Czechowska, A. | +4

8

Tyrosine kinases. New target of anticancer therapy

enthalten in: Postepy biochemii | 2005

von Majsterek, I. | Pytel, D. | Błasiak, J.

1
[1]